Metabolic Signaling in Cancer Metastasis

S Krieg, SI Fernandes, C Kolliopoulos, M Liu, SM Fendt - Cancer Discovery, 2024 - AACR
Metastases, which are the leading cause of death in patients with cancer, have metabolic
vulnerabilities. Alterations in metabolism fuel the energy and biosynthetic needs of …

Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis

C Lu, P Qiao, R Fu, Y Wang, J Lu, X Ling, L Liu… - Cell Death & …, 2022 - nature.com
Endometriosis (EM) is one of the vanquished wonted causes of chronic pelvic sting in
women and is closely associated with infertility. The long-term, complex, systemic, and post …

Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: From underlying mechanisms to targeted therapeutics

W Jin, J Zhang, X Chen, S Yin, H Yu, F Gao… - Biochimica et Biophysica …, 2023 - Elsevier
Coactivator-associated arginine methyltransferase 1 (CARM1), a type I protein arginine
methyltransferase (PRMT), has been widely reported to catalyze arginine methylation of …

THOC3 interacts with YBX1 to promote lung squamous cell carcinoma progression through PFKFB4 mRNA modification

T Yu, Q Zhang, SK Yu, FQ Nie, ML Zhang… - Cell Death & …, 2023 - nature.com
The THO complex (THOC) is ubiquitously involved in RNA modification and various THOC
proteins have been reported to regulate tumor development. However, the role of THOC3 in …

Hypoxia-mediated promotion of glucose metabolism in non-small cell lung cancer correlates with activation of the EZH2/FBXL7/PFKFB4 axis

J Zhou, Y Lin, X Kang, Z Liu, J Zou, F Xu - Cell Death & Disease, 2023 - nature.com
F-box/LRR-repeat protein 7 (FBXL7) was predicted as a differentially expressed E3 ubiquitin
ligase in non-small cell lung cancer (NSCLC), which has been suggested to influence …

PFKFB4 facilitates palbociclib resistance in oestrogen receptor‐positive breast cancer by enhancing stemness

S Wang, Y Bei, Q Tian, J He, R Wang, Q Wang… - Cell …, 2023 - Wiley Online Library
Background ER+ breast cancer (ER+ BC) is the most common subtype of BC. Recently,
CDK4/6 inhibitors combined with aromatase inhibitors have been approved by FDA as the …

Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker

Y Qiu, H Wang, P Liao, B Xu, R Hu, Y Yang, Y Li - BMC Genomic Data, 2022 - Springer
Background Belonging to the protein arginine methyltransferase (PRMT) family, the enzyme
encoded by coactivator associated arginine methyltransferase 1 (CARM1) catalyzes the …

[HTML][HTML] Effect of PFKFB4 on the Prognosis and Immune Regulation of NSCLC and Its Mechanism

Y Zhou, Y Fan, B Qiu, M Lou, X Liu… - International Journal of …, 2022 - ncbi.nlm.nih.gov
Background NSCLC (non-small cell lung cancer) has become the malignancy with the
highest incidence and mortality rate worldwide. Fructose-6-phosphate 2-kinase/fructose-2, 6 …

β-elemene Isopropanolamine Derivative LXX-8250 Induces Apoptosis Through Impairing Autophagic Flux via PFKFB4 Repression in Melanoma Cells

S Jalal, T Zhang, J Deng, J Wang, T Xu… - Frontiers in …, 2022 - frontiersin.org
Melanoma is a highly aggressive skin cancer and accounts for most of the skin cancer-
related deaths. The efficacy of current therapies for melanoma remains to be improved. The …

Reprogramming of glucose metabolism via PFKFB4 is critical in FGF16-driven invasion of breast cancer cells

S Kar, N Maji, K Sen, S Roy, A Maity… - Bioscience …, 2023 - portlandpress.com
Fibroblast growth factors (FGFs) are expressed in both developing and adult tissues and
play important roles in embryogenesis, tissue homeostasis, angiogenesis, and neoplastic …